162 related articles for article (PubMed ID: 19293387)
1. Endocannabinoids: The silent partner of glucocorticoids in the synapse.
Hill MN; McEwen BS
Proc Natl Acad Sci U S A; 2009 Mar; 106(12):4579-80. PubMed ID: 19293387
[No Abstract] [Full Text] [Related]
2. Endocannabinoids in the rat basolateral amygdala enhance memory consolidation and enable glucocorticoid modulation of memory.
Campolongo P; Roozendaal B; Trezza V; Hauer D; Schelling G; McGaugh JL; Cuomo V
Proc Natl Acad Sci U S A; 2009 Mar; 106(12):4888-93. PubMed ID: 19255436
[TBL] [Abstract][Full Text] [Related]
3. Chronic corticosterone treatment increases the endocannabinoid 2-arachidonylglycerol in the rat amygdala.
Hill MN; Ho WS; Meier SE; Gorzalka BB; Hillard CJ
Eur J Pharmacol; 2005 Dec; 528(1-3):99-102. PubMed ID: 16324692
[TBL] [Abstract][Full Text] [Related]
4. Pre-training anandamide infusion within the basolateral amygdala impairs plus-maze discriminative avoidance task in rats.
Munguba H; Cabral A; Leão AH; Barbosa FF; Izídio GS; Ribeiro AM; Silva RH
Neurobiol Learn Mem; 2011 May; 95(4):527-33. PubMed ID: 21440651
[TBL] [Abstract][Full Text] [Related]
5. The endogenous cannabinoid system controls extinction of aversive memories.
Marsicano G; Wotjak CT; Azad SC; Bisogno T; Rammes G; Cascio MG; Hermann H; Tang J; Hofmann C; Zieglgänsberger W; Di Marzo V; Lutz B
Nature; 2002 Aug; 418(6897):530-4. PubMed ID: 12152079
[TBL] [Abstract][Full Text] [Related]
6. Disruption of endocannabinoid release and striatal long-term depression by postsynaptic blockade of endocannabinoid membrane transport.
Ronesi J; Gerdeman GL; Lovinger DM
J Neurosci; 2004 Feb; 24(7):1673-9. PubMed ID: 14973237
[TBL] [Abstract][Full Text] [Related]
7. Endocannabinoid-mediated enhancement of fear-conditioned analgesia in rats: opioid receptor dependency and molecular correlates.
Butler RK; Rea K; Lang Y; Gavin AM; Finn DP
Pain; 2008 Dec; 140(3):491-500. PubMed ID: 19004548
[TBL] [Abstract][Full Text] [Related]
8. Propofol enhances memory formation via an interaction with the endocannabinoid system.
Hauer D; Ratano P; Morena M; Scaccianoce S; Briegel I; Palmery M; Cuomo V; Roozendaal B; Schelling G; Campolongo P
Anesthesiology; 2011 Jun; 114(6):1380-8. PubMed ID: 21532463
[TBL] [Abstract][Full Text] [Related]
9. Glucocorticoid interactions with the dorsal striatal endocannabinoid system in regulating inhibitory avoidance memory.
Siller-Pérez C; Fuentes-Ibañez A; Sotelo-Barrera EL; Serafín N; Prado-Alcalá RA; Campolongo P; Roozendaal B; Quirarte GL
Psychoneuroendocrinology; 2019 Jan; 99():97-103. PubMed ID: 30216767
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms for synapse specificity during striatal long-term depression.
Singla S; Kreitzer AC; Malenka RC
J Neurosci; 2007 May; 27(19):5260-4. PubMed ID: 17494712
[TBL] [Abstract][Full Text] [Related]
11. Differential role of the hippocampal endocannabinoid system in the memory consolidation and retrieval mechanisms.
De Oliveira Alvares L; Genro BP; Diehl F; Quillfeldt JA
Neurobiol Learn Mem; 2008 Jul; 90(1):1-9. PubMed ID: 18342551
[TBL] [Abstract][Full Text] [Related]
12. Rapid elevations in limbic endocannabinoid content by glucocorticoid hormones in vivo.
Hill MN; Karatsoreos IN; Hillard CJ; McEwen BS
Psychoneuroendocrinology; 2010 Oct; 35(9):1333-8. PubMed ID: 20399021
[TBL] [Abstract][Full Text] [Related]
13. Repeated homotypic stress elevates 2-arachidonoylglycerol levels and enhances short-term endocannabinoid signaling at inhibitory synapses in basolateral amygdala.
Patel S; Kingsley PJ; Mackie K; Marnett LJ; Winder DG
Neuropsychopharmacology; 2009 Dec; 34(13):2699-709. PubMed ID: 19675536
[TBL] [Abstract][Full Text] [Related]
14. Serotonin evokes endocannabinoid release and retrogradely suppresses excitatory synapses.
Best AR; Regehr WG
J Neurosci; 2008 Jun; 28(25):6508-15. PubMed ID: 18562622
[TBL] [Abstract][Full Text] [Related]
15. The cannabinoid transporter inhibitor OMDM-2 reduces social interaction: Further evidence for transporter-mediated endocannabinoid release.
Seillier A; Giuffrida A
Neuropharmacology; 2018 Mar; 130():1-9. PubMed ID: 29169961
[TBL] [Abstract][Full Text] [Related]
16. Activation of endocannabinoid system in the rat basolateral amygdala improved scopolamine-induced memory consolidation impairment.
Nedaei SE; Rezayof A; Pourmotabbed A; Nasehi M; Zarrindast MR
Behav Brain Res; 2016 Sep; 311():183-191. PubMed ID: 27230394
[TBL] [Abstract][Full Text] [Related]
17. Reduction in endocannabinoid tone is a homeostatic mechanism for specific inhibitory synapses.
Kim J; Alger BE
Nat Neurosci; 2010 May; 13(5):592-600. PubMed ID: 20348918
[TBL] [Abstract][Full Text] [Related]
18. Endocannabinoid liberation from neurons in transsynaptic signaling.
Lovinger DM
J Mol Neurosci; 2007 Sep; 33(1):87-93. PubMed ID: 17901551
[TBL] [Abstract][Full Text] [Related]
19. CB1 receptor-mediated control of the release of endocannabinoids (as assessed by microdialysis coupled with LC/MS) in the rat hypothalamus.
Béquet F; Uzabiaga F; Desbazeille M; Ludwiczak P; Maftouh M; Picard C; Scatton B; Le Fur G
Eur J Neurosci; 2007 Dec; 26(12):3458-64. PubMed ID: 18052990
[TBL] [Abstract][Full Text] [Related]
20. Interactions between ethanol and the endocannabinoid system at GABAergic synapses on basolateral amygdala principal neurons.
Talani G; Lovinger DM
Alcohol; 2015 Dec; 49(8):781-94. PubMed ID: 26603632
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
